Humana Inc. HUM
- Market cap
- $45.7B
- P/E
- 37.4×
Follow HUM
Humana Inc. (HUM) Free cash flow
Humana Inc.'s free cash flow for fiscal 2025 was $398.0M, down 83.4% from $2.4B in fiscal 2024. Over the twelve months to 30 June 2026 it was $2.0B. Over the past ten years it has ranged from $346.0M (fiscal 2015) to $4.7B (fiscal 2020); the current reading is higher than 18% of that period. Free cash flow has fallen for 3 consecutive fiscal years. Humana Inc. ranks 7th of 12 Healthcare Plans companies by free cash flow.
Free cash flow, annual
Annual
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $398.0M | (83.40%) |
| FY2024 | $2.4B | (24.76%) |
| FY2023 | $3.2B | (8.08%) |
| FY2022 | $3.5B | 266.49% |
| FY2021 | $946.0M | (79.76%) |
| FY2020 | $4.7B | 2.79% |
| FY2019 | $4.5B | 191.35% |
| FY2018 | $1.6B | (55.74%) |
| FY2017 | $3.5B | 150.32% |
| FY2016 | $1.4B | 307.23% |
Quarterly
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $1.8B | 61.87% |
| Mar 2026 | $1.1B | — |
| Dec 2025 | −$1.8B | — |
| Sep 2025 | $836.0M | (27.74%) |
| 42 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $23.6B |
| CVS CVS Health Corporation compare | $11.8B |
| CI Cigna Group compare | $9.1B |
| CNC Centene Corporation compare | $9.0B |
| ELV Elevance Health, Inc. compare | $6.3B |
| OSCR Oscar Health, Inc. compare | $4.4B |
| HUM Humana Inc. | $2.0B |
| MOH Molina Healthcare, Inc compare | $271.0M |
| CLOV Clover Health Investments, Corp. compare | $74.2M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on HUM
- Revenue
- Net income
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement